CAS 1228591-30-7

TAK-632

Description:

TAK-632, with the CAS number 1228591-30-7, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of cancer treatment. It is classified as a small molecule inhibitor, specifically targeting certain kinases involved in cellular signaling pathways that regulate cell growth and proliferation. The compound exhibits selective inhibition, which is crucial for minimizing off-target effects and enhancing therapeutic efficacy. TAK-632 has shown promise in preclinical studies for its potential to disrupt tumor growth and improve outcomes in various cancer models. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are essential for determining its suitability for clinical use. Additionally, ongoing research aims to elucidate its mechanism of action, optimal dosing regimens, and potential combination therapies with other anticancer agents. As with many investigational drugs, further studies are necessary to fully understand its safety profile and therapeutic potential in human subjects.

N-[7-cyano-6-(4-fluoro-3-{2-[3-(trifluoromethyl)phenyl]acetamido}phenoxy)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide

CAS: 1228591-30-7

Formula: C₂₇H₁₈F₄N₄O₃S

Purity: 98%

Color and Shape: Solid

Molecular weight: 554.5154

Ref: IN-DA000JM1

TAK-632

CAS: 1228591-30-7

TAK-632

Purity: ≥98%

Molecular weight: 554.52g/mol

Ref: 54-BUP10694

TAK-632

CAS: 1228591-30-7

Ref: 7W-GW3025

TAK-632

CAS: 1228591-30-7

TAK-632 is a potent pan-Raf inhibitor.

Formula: C₂₇H₁₈F₄N₄O₃S

Purity: 98% - 99.5%

Color and Shape: Solid

Molecular weight: 554.52

Ref: TM-T1886

TAK 632

CAS: 1228591-30-7

Inhibitor of pan-Raf kinases

Formula: C₂₇H₁₈F₄N₄O₃S

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 554.52 g/mol

Ref: 3D-FC103614